Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yoel Vivas

Clinical Cardiac Electrophysiology Delray Beach, FL Medical Doctor

NPI 1619130291 CMS profile 437730

5258 Linton Blvd Ste 106, Delray Beach, FL 33484

Open in the dashboard

General payments

$267,695

1,517 records reported · program years 2019–2025

Research payments

$66,900

Paid to them · 11 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$40,142 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Yoel Vivas of Delray Beach, FL is reported in the CMS Open Payments database as having received $267,695 across 1,517 general payments and $66,900 in research payments paid to them. Separately, studies naming them as principal investigator received $40,142 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $89,446 249
2024 General $54,154 373
2023 General $36,295 259
2022 General $23,664 240
2021 General $28,217 166
2020 General $15,462 92
2020 Research $55,673 5
2019 General $20,458 138
2019 Research $11,227 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yoel Vivas
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Yoel Vivas were reported at $89,446. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Yoel Vivas Clinical Cardiac Electrophysiology median Middle half National median
2019 $20,458 $2,361 $585–$8,260 $163
2020 $15,462 $993 $247–$4,351 $114
2021 $28,217 $1,185 $326–$4,739 $132
2022 $23,664 $2,073 $554–$6,789 $149
2023 $36,295 $2,568 $759–$8,159 $160
2024 $54,154 $2,557 $703–$7,403 $164
2025 $89,446 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $137,692 802 payments
  2. Boston Scientific Corporation $54,303 191 payments
  3. Acutus Medical, Inc. $13,767 57 payments
  4. Aziyo Biologics, Inc. $12,618 95 payments
  5. Medtronic Vascular, Inc. $10,709 17 payments
  6. Biotronik Inc. $10,041 55 payments
  7. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $6,671 49 payments
  8. Atricure, Inc. $5,500 24 payments
  9. Volta Medical Inc $4,566 18 payments
  10. AltaThera Pharmaceuticals LLC $4,041 7 payments
  11. Other $7,786 202 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $96,183 67 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $63,105 47 payments
  3. Food and Beverage $51,418 1,293 payments
  4. Travel and Lodging $34,880 84 payments
  5. Honoraria $13,426 18 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,870 4 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $3,800 3 payments
  8. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. General - EP $36,008 36 payments
  2. AMPLATZER AMULET $24,612 72 payments
  3. ENSITE Electrophysiology $24,606 118 payments
  4. ENSITE Structural Heart $23,250 24 payments
  5. ECM Patch,Pouch $11,109 92 payments
  6. ENSITE PRECISION $10,788 41 payments
  7. LifeVest $6,671 49 payments
  8. TACTICATH ABLATION CATHETER, SENSOR ENABLED $6,442 6 payments
  9. EnSite Precision Cardiac Mapping System $5,791 40 payments
  10. Ensite Cardiac Mapping System $4,983 30 payments
  11. Other $76,913 889 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abbott Laboratories $66,900 11 payments

Prescribing to Medicare patients

Part D · data year 2024 · 23 drugs

Part D claims

1,675

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$543,644

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

46.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 385 $343,403
Multaq Dronedarone Hcl Brand 88 $95,170
Xarelto Rivaroxaban Brand 80 $86,119
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 17 $4,284
Metoprolol Succinate Generic 275 $3,511
Sotalol Sotalol Hcl Brand 116 $2,274
Amiodarone Hcl Generic 127 $1,723
Flecainide Acetate Generic 56 $1,668
Fludrocortisone Acetate Generic 26 $811
Clopidogrel Clopidogrel Bisulfate Brand 63 $661

The 10 drugs with the highest cost, of 23 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$542,540

Medicare's payments for the services billed

Medicare patients

1,565

Average age 80

Services billed

6,004

776 women, 789 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 62%
Ischemic heart disease 61%
Arthritis 59%
Chronic kidney disease 49%
Heart failure 45%
Diabetes 40%
Depression 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Sotalol Hydrochloride
$632 116 —
MULTAQ
$75 88 —
XARELTO
$73 80 —
ELIQUIS
$36 385 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,528 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record